Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The biologic basis for neuroblastoma heterogeneity and risk stratification.

Current opinion in pediatrics - 1 Feb 2005

Maris John M

Abstract excerpt

PURPOSE OF REVIEW: Neuroblastoma serves as the paradigm for the clinical utility of tumor-specific biologic data for prognostication. This review will describe the genetic and biologic basis for the diverse clinical phenotypes observed in neuroblastoma patients. It will also discuss the current approach to risk classification and how this may change in the future. RECENT FINDINGS: The biologic basis of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Alleles
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Heterogeneity

Share to Homeodomain Proteins

Share to Nerve Growth Factors

Share to Neuroblastoma

Share to Transcription Factors

Source

Identifiers

PMID: 15659956
DOI: 10.1097/01.mop.0000150631.60571.89

Genes

MYCN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The biologic basis for neuroblastoma heterogeneity and risk stratification.PMID 15659956Read ↗

Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies.Semantic proximity Read ↗

Neuroblastoma: biology, prognosis, and treatment.Semantic proximity Read ↗

The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapySemantic proximity Read ↗

Advances in Risk Classification and Treatment Strategies for NeuroblastomaSemantic proximity Read ↗

Genetic discoveries and treatment advances in neuroblastoma.Semantic proximity Read ↗

The Evolution of Risk Classification for NeuroblastomaSemantic proximity Read ↗

Genetic susceptibility to neuroblastoma: current knowledge and future directions.Semantic proximity Read ↗

Recent insights into the biology of neuroblastomaSemantic proximity Read ↗

Molecular Genetics in Neuroblastoma PrognosisSemantic proximity Read ↗

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeSemantic proximity Read ↗

Neuroblastoma: biology and staging.Semantic proximity Read ↗

The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic ApproachesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.